Boston Scientific funnels $1.5B into MiRus, with option to buy TAVR system

🌐 Fierce Biotech —
Boston Scientific funnels $1.5B into MiRus, with option to buy TAVR system

AI Summary

Boston Scientific has committed $1.5 billion into MiRus, which includes an option to acquire a transcatheter aortic valve replacement (TAVR) system. This investment may signal significant advancements in heart valve technologies and treatments.

Deals Health Boston Scientific MiRus TAVR healthcare investment cardiology

Read original source →